Methods |
RCT, duration of study 4/52 |
Participants |
35 women
Inclusion criteria: urgency symptoms, urgency urinary incontinence, frequency, nocturia
Exclusion criteria: renal disease, infections in the urogenital area, anticholinergic or hormone therapy |
Interventions |
Group A (n=15): 0.5 or 1 mg oestriol vaginally
Group B (n=20): 2 mg oestriol vaginally |
Outcomes |
Urinary diary, cystoscopy, urodynamics, urethral and vaginal smear |
Notes |
No endometrial stimulation or breast tenderness noted |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
no description |
Allocation concealment (selection bias) |
Unclear risk |
no description |
Blinding (performance bias and detection bias)
All outcomes |
Unclear risk |
no description |
Incomplete outcome data (attrition bias)
All outcomes |
Unclear risk |
no description |